The Balancing Act For HealthTech Providers In The Post-COVID-19 Era Of Volatility
Executive Summary
How quickly health care delivery returns to pre-COVID-19 routines is the million-dollar question. With coronavirus volatility still a worrying reality and the burden of chronic care ever present, medtech companies that partner with provider systems must ensure they are covering all the bases. For Royal Philips’ Roy Jakobs, this means delivering on the promises of connected care.
You may also be interested in...
Philips Healthcare: Targeting Healthtech Market Recovery Via Value Creation
Quality issues relating to a historical acquisition have held back Philips Healthcare’s financial performance in the post-COVID phase, while market competitors have been able to chart a less bumpy path through the tail end of the pandemic. All are facing supply chain and inflationary pressures.
Philips Healthcare: Targeting Healthtech Market Recovery Via Value Creation
Quality issues relating to a historical acquisition have held back Philips Healthcare’s financial performance in the post-COVID phase, while market competitors have been able to chart a less bumpy path through the tail end of the pandemic. All are facing supply chain and inflationary pressures.
Improving Health Care Productivity Means ‘Locking Arms With Providers’
Royal Philips would not routinely invest 10% of its sales in R&D without working with providers to discover their precise needs, says CEO Frans van Houten.